MREO Financial Facts
Services: 62.25KProduct: 20.37K
See Full Income Statement
Accrued expenses: 63.68K
Due to officers: 70.5K
See Full Balance Sheet
Mereo BioPharma Group plc (MREO) Earnings
|
Expand Research on MREO
| Next EPS Date | 8/18/26 | EPS Growth Rate | +50.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -75.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/26  |
Q226 | N/A | -$0.01 | N/A | N/A | $2.33M | N/A | N/A | N/A | ||
| 5/12/26 |
Q126 | -$0.01 | -$0.01 | $0.00 | N/A | $17.5M | N/A |  | | Details | |
| 4/1/26 |
Q126 | N/A | -$0.01 | N/A | N/A | $30M | N/A | N/A | N/A | ||
| 11/18/25 |
Q325 | N/A | $0.01 | N/A | N/A | $17.5M | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | -$0.02 | $0.00 | -$0.02 | N/A | N/A | N/A | | | Details | |
| 5/13/25 |
Q125 | -$0.02 | $0.01 | -$0.03 | N/A | $26.88M | N/A | | | Details | |
| 3/26/25 |
Q424 | N/A | -$0.01 | N/A | N/A | $36.25M | N/A | N/A | N/A | ||
| 9/17/24 | Q324 | N/A | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A |
